Digital Therapeutics (DTx) is a rapidly growing area of Digital Health.
Gill Jennings & Every LLP's recent whitepaper explains how innovators can navigate the challenges to securing patent protection for software-based therapeutics in Europe.
Stay ahead in digital health IP strategy and access Jack Severs' full article here.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.